HomeCommentary

Commentary

High Hopes for New Osteoporosis Drugs, but “Treatment Gap” Needs to Be Addressed
(Nov.27.2015)

Doctors who specialize in osteoporosis have high hopes for a number of new drugs that are currently in development. Cathepsin K inhibitors, which could debut in the near future, anti-sclerostin antibodies, and parathyroid hormone-related protein (PTHrP) analogs have attracted particular ...

(LOG IN FOR FULL STORY)

News Calendar